BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22637473)

  • 1. Critical determinants of human α-defensin 5 activity against non-enveloped viruses.
    Gounder AP; Wiens ME; Wilson SS; Lu W; Smith JG
    J Biol Chem; 2012 Jul; 287(29):24554-62. PubMed ID: 22637473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition.
    Tenge VR; Gounder AP; Wiens ME; Lu W; Smith JG
    PLoS Pathog; 2014 Sep; 10(9):e1004360. PubMed ID: 25188351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.
    Wang A; Chen F; Wang Y; Shen M; Xu Y; Hu J; Wang S; Geng F; Wang C; Ran X; Su Y; Cheng T; Wang J
    J Virol; 2013 Mar; 87(5):2835-45. PubMed ID: 23269800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome.
    Wiens ME; Smith JG
    mBio; 2017 Jan; 8(1):. PubMed ID: 28119475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
    Wiens ME; Smith JG
    J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization.
    Smith JG; Silvestry M; Lindert S; Lu W; Nemerow GR; Stewart PL
    PLoS Pathog; 2010 Jun; 6(6):e1000959. PubMed ID: 20585634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity.
    Valere K; Lu W; Chang TL
    Viruses; 2017 Aug; 9(9):. PubMed ID: 28850095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5.
    Flatt JW; Kim R; Smith JG; Nemerow GR; Stewart PL
    PLoS One; 2013; 8(4):e61571. PubMed ID: 23620768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability.
    Rajabi M; de Leeuw E; Pazgier M; Li J; Lubkowski J; Lu W
    J Biol Chem; 2008 Aug; 283(31):21509-18. PubMed ID: 18499668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional determinants of human enteric α-defensin HD5: crucial role for hydrophobicity at dimer interface.
    Rajabi M; Ericksen B; Wu X; de Leeuw E; Zhao L; Pazgier M; Lu W
    J Biol Chem; 2012 Jun; 287(26):21615-27. PubMed ID: 22573326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a potent antibiotic peptide based on the active region of human defensin 5.
    Wang C; Shen M; Gohain N; Tolbert WD; Chen F; Zhang N; Yang K; Wang A; Su Y; Cheng T; Zhao J; Pazgier M; Wang J
    J Med Chem; 2015 Apr; 58(7):3083-93. PubMed ID: 25782105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs.
    Mathew B; Nagaraj R
    Peptides; 2015 Sep; 71():128-40. PubMed ID: 26206286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The penetration of human defensin 5 (HD5) through bacterial outer membrane: simulation studies.
    Awang T; Pongprayoon P
    J Mol Model; 2021 Sep; 27(10):291. PubMed ID: 34546425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Defensin HD5 Stabilizes
    Gulati NM; Miyagi M; Wiens ME; Smith JG; Stewart PL
    Pathog Immun; 2019; 4(2):196-234. PubMed ID: 31583330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy.
    Vragniau C; Hübner JM; Beidler P; Gil S; Saydaminova K; Lu ZZ; Yumul R; Wang H; Richter M; Sova P; Drescher C; Fender P; Lieber A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study.
    Zhang L
    Proteins; 2017 Apr; 85(4):665-681. PubMed ID: 28106297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Function and Modification of Human Defensin 5.
    Chang XY; Zhang MW; Zhang LJ; Chai LQ
    Protein Pept Lett; 2023; 30(10):830-840. PubMed ID: 37861034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivalent binding of carbohydrates by the human alpha-defensin, HD5.
    Lehrer RI; Jung G; Ruchala P; Andre S; Gabius HJ; Lu W
    J Immunol; 2009 Jul; 183(1):480-90. PubMed ID: 19542459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.
    Dugan AS; Maginnis MS; Jordan JA; Gasparovic ML; Manley K; Page R; Williams G; Porter E; O'Hara BA; Atwood WJ
    J Biol Chem; 2008 Nov; 283(45):31125-32. PubMed ID: 18782756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the Bacterial Membrane Disruption Mechanism of Human α-Defensin 5: A Theoretical Study.
    Jung SW; Lee J; Cho AE
    J Phys Chem B; 2017 Feb; 121(4):741-748. PubMed ID: 28067516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.